February 19, 2021
A company-initiated recall of two models of EMBLEM S-ICD (Boston Scientific) subcutaneous implantable cardioverter defibrillator pulse generators has been categorized as Class I by the US […]
February 17, 2021
Medtronic is voluntarily recalling unused Valiant Navion thoracic stent grafts worldwide after reports of stent fractures surfaced from the Valiant Evo Global clinical trial. Two patients […]
February 17, 2021
The US Food and Drug Administration (FDA) has approved a groundbreaking expanded indication for sacubitril/valsartan (Entresto), making it the first drug in the United States indicated […]
February 16, 2021
Shockwave Medical’s Intravascular Lithotripsy (IVL) system has received premarket approval from the US Food and Drug Administration (FDA) to treat severely calcified coronary artery disease, the […]
February 15, 2021
A novel drug that offers multilineage protection from chemotherapy-induced myelosuppression has been approved by the US Food and Drug Administration. The drug, trilaciclib (Cosela, G1 Therapeutics) […]
February 11, 2021
The US Food and Drug Administration has approved the fully human monoclonal antibody evinacumab-dgnb (Evkeeza, Regeneron Pharmaceuticals) for use on top of other cholesterol-modifying meds in […]
February 11, 2021
The Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention (CDC) has updated its recommended immunization schedule for adults for 2021. […]
February 11, 2021
The Centers for Disease Control and Prevention (CDC) today released the 2021 Childhood and Adolescent Immunization Schedule. It includes relatively few changes from last year’s schedule […]
February 10, 2021
The Food and Drug Administration has approved cemiplimab-rwlc (Libtayo) as the first immunotherapy to treat patients with locally advanced or metastatic basal cell carcinoma (BCC) previously […]